Bessemer Group Inc Bio Techne Corp Transaction History

Bessemer Group Inc

$60.7 Billion
Q3 2024

A detailed history of Bessemer Group Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Bessemer Group Inc holds 81,589 shares of TECH stock, worth $5.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

81,589

Previous 39,729 105.36%

Holding current value

$5.9 Million

Previous $2.85 Million 129.13%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$70.96 - $82.35 $2.97 Million - $3.45 Million	41,860 Added 105.36%	81,589 $6.52 Million
Q2 2024 Aug 13, 2024	SELL	$62.12 - $84.15 $65,039 - $88,105	-1,047 Reduced 2.57%	39,729 $2.85 Million
Q1 2024 May 13, 2024	BUY	$65.98 - $77.09 $1.45 Million - $1.7 Million	22,037 Added 117.6%	40,776 $2.87 Million
Q4 2023 Feb 09, 2024	SELL	$52.83 - $78.22 $48,286 - $71,493	-914 Reduced 4.65%	18,739 $1.45 Million
Q3 2023 Nov 13, 2023	BUY	$67.52 - $89.42 $43,955 - $58,212	651 Added 3.43%	19,653 $1.34 Million
Q2 2023 Aug 10, 2023	SELL	$73.76 - $85.98 $225,115 - $262,410	-3,052 Reduced 13.84%	19,002 $1.55 Million
Q1 2023 May 10, 2023	SELL	$71.62 - $86.62 $132,711 - $160,506	-1,853 Reduced 7.75%	22,054 $1.64 Million
Q4 2022 Feb 13, 2023	BUY	$80.67 - $352.29 $1.52 Million - $6.64 Million	18,844 Added 372.19%	23,907 $1.98 Million
Q3 2022 Nov 09, 2022	BUY	$282.54 - $391.85 $196,647 - $272,727	696 Added 15.94%	5,063 $1.44 Million
Q2 2022 Aug 10, 2022	BUY	$322.67 - $449.65 $296,856 - $413,678	920 Added 26.69%	4,367 $1.51 Million
Q1 2022 May 12, 2022	BUY	$353.85 - $487.79 $491,497 - $677,540	1,389 Added 67.49%	3,447 $1.49 Million
Q4 2021 Jan 27, 2022	BUY	$456.15 - $525.06 $411,903 - $474,129	903 Added 78.18%	2,058 $1.07 Million
Q3 2021 Nov 12, 2021	BUY	$444.87 - $538.88 $21,353 - $25,866	48 Added 4.34%	1,155 $559,000
Q2 2021 Aug 06, 2021	BUY	$387.35 - $450.26 $13,169 - $15,308	34 Added 3.17%	1,107 $498,000
Q1 2021 May 13, 2021	SELL	$314.62 - $411.0 $215,200 - $281,124	-684 Reduced 38.93%	1,073 $409,000
Q4 2020 Feb 09, 2021	BUY	$246.9 - $321.87 $4,938 - $6,437	20 Added 1.15%	1,757 $558,000
Q3 2020 Nov 12, 2020	SELL	$232.22 - $282.96 $811,376 - $988,662	-3,494 Reduced 66.79%	1,737 $430,000
Q2 2020 Aug 05, 2020	BUY	$185.43 - $279.56 $868,183 - $1.31 Million	4,682 Added 852.82%	5,231 $1.38 Million
Q2 2019 Jul 19, 2019	BUY	$188.72 - $215.43 $95,681 - $109,223	507 Added 1207.14%	549 $114,000
Q1 2019 May 13, 2019	SELL	$136.09 - $200.44 $165,621 - $243,935	-1,217 Reduced 96.66%	42 $8,000
Q4 2018 Feb 12, 2019	BUY	$132.75 - $203.8 $4,911 - $7,540	37 Added 3.03%	1,259 $182,000
Q3 2018 Nov 06, 2018	SELL	$147.44 - $204.11 $48,360 - $66,948	-328 Reduced 21.16%	1,222 $249,000
Q2 2018 Jul 25, 2018	SELL	$144.9 - $165.58 $325,735 - $372,223	-2,248 Reduced 59.19%	1,550 $230,000
Q1 2018 May 10, 2018	SELL	$131.46 - $151.04 $474,307 - $544,952	-3,608 Reduced 48.72%	3,798 $574,000
Q4 2017 Jan 30, 2018	BUY	$121.17 - $134.75 $12,117 - $13,475	100 Added 1.37%	7,406 $959,000
Q3 2017 Nov 03, 2017	BUY	$113.59 - $123.78 $829,888 - $904,336	7,306	7,306 $882,000

Others Institutions Holding TECH

# of Institutions

602

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.84B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account

Bessemer Group Inc Bio Techne Corp Transaction History